`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AMNEAL PHARMACEUTICALS LLC AND
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALMIRALL, LLC,
`Patent Owner.
`
`Case IPR2019-00207
`Patent 9,517,219
`
`
`
`
`PATENT OWNER ALMIRALL, LLC’S NOTICE OF DEPOSITION OF
`DR. ELAINE S. GILMORE, M.D., PH.D. UNDER 37 C.F.R. § 42.53
`
`
`
`
`
`
`
`IPR2019-00207
`Notice of Deposition of Dr. Gilmore
`
`
`PLEASE TAKE NOTICE that pursuant to 37 C.F.R. § 42.53, Patent Owner
`
`Almirall, LLC will take the deposition of Petitioners’ declarant, Dr. Elaine S. Gilmore,
`
`M.D., Ph.D. upon oral examination as follows.
`
`Date:
`
`December 12, 2019
`
`Time:
`
`8:00 a.m.
`
`Location: Sterne, Kessler, Goldstein & Fox P.L.L.C.
`1100 New York Avenue
`NW Washington, DC 20005
`
`The deposition will be recorded by stenographic and/or audio means by a court
`
`reporter licensed to administer oaths.
`
`
`
`Dated: November 25, 2019
`
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By: /James Trainor/
`James Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`1
`
`
`
`
`
`
`
`
`
`IPR2019-00207
`Notice of Deposition of Dr. Gilmore
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that the foregoing PATENT
`
`OWNER ALMIRALL, LLC’S NOTICE OF DEPOSITION OF DR. ELAINE
`
`S. GILMORE, M.D., PH.D. UNDER 37 C.F.R. § 42.53 was served by electronic
`
`mail on the following counsel of record for petitioner:
`
`
`
`
`
`
`
`
`
`
`Dennies Varughese (dvarughe-PTAB@skgf.com)
`Adam C. LaRock (alarock-PTAB@skgf.com)
`Tyler C. Liu (tliu-PTAB@skgf.com)
`PTAB@skgf.com
`Sterne, Kessler, Goldstein & Fox
`1100 New York Avenue, NW
`Suite 600
`Washington, DC 20005
`
`
`
`Dated: November 25, 2019
`
`
`
`
`
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By: /James Trainor/
`James Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`
`
`2
`
`